Moxifloxacina Rompharm (Moxifloxacin Hydrochloride)

Moxifloxacin Hydrochloride, the active ingredient in Moxifloxacina Rompharm, is a fluoroquinolone antibiotic presented as an ophthalmic preparation for ocular use. It treats bacterial conjunctivitis, bacterial keratitis and other susceptible ocular bacterial infections in patients requiring topical therapy.

GNH USA supplies Moxifloxacina Rompharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacina Rompharm is a fluoroquinolone antibiotic used to manage bacterial infections of the eye.

- Bacterial conjunctivitis: reduces bacterial load and resolves infection of the conjunctiva. - Bacterial keratitis: eradicates causative organisms and promotes corneal healing. - Other susceptible ocular bacterial infections: provides broad‑spectrum antibacterial activity for various eye infections.

Moxifloxacina Rompharm may cause ocular and systemic adverse reactions.

Common Side Effects: - Burning or stinging sensation upon instillation. - Redness of the eye. - Tearing or increased lacrimation. - Foreign body sensation. - Blurred vision. - Mild itching.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis). - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Toxic anterior segment syndrome. - Corneal ulceration or perforation. - Vision loss. - Systemic hypersensitivity reactions.

Before prescribing Moxifloxacina Rompharm, consider the following precautions.

- Allergy assessment: confirm no known hypersensitivity to fluoroquinolones. - Pregnancy and lactation: use only if benefits outweigh potential risks; data are limited. - Contact lens wearers: remove lenses before administration and avoid re‑insertion until after dosing. - Concomitant ocular medications: avoid simultaneous use unless directed by a clinician. - Monitor for systemic fluoroquinolone effects such as tendonitis or CNS disturbances. - Store at room temperature: keep in the original container, protect from light and moisture.

Moxifloxacina Rompharm can interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use may increase systemic exposure and toxicity. - Corticosteroid eye drops: may raise the risk of corneal perforation. - Anticholinergic agents: may reduce ocular absorption of the antibiotic.

Moderate Interactions (Monitor Closely): - Nonsteroidal anti‑inflammatory eye drops: may affect corneal healing. - Herbal supplements containing quinine: potential additive toxicity. - Other ophthalmic antibiotics: assess for additive ocular toxicity.